本文通过系统评价和荟萃分析，研究 PI-RADS 2.1 升级规则对前列腺移行带（TZ）病变中前列腺癌（PCa）检出率的影响。发现 “2 + 1” 和 “3 + 1” 病变的癌症风险符合评分系统，但假阳性率高，对活检决策意义重大。 研究背景 磁共振成像（MRI）在前列腺癌（PCa）的 ...

本文综述了多参数磁共振成像（mpMRI）及前列腺影像报告和数据系统（PI-RADS）在黑人与白人前列腺癌（PCa）患者中的应用差异。研究表明，PI-RADS评分可能存在种族特异性偏差，PI-RADS 3分病灶对黑人患者更具临床意义。因此，对于黑人患者，即使mpMRI阴性或为PI-RADS ...

Shifting patterns of care in localized prostate cancer: Impact on patient reported outcome measures (PROMs). This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does ...

Disparities in receipt of molecular imaging in biochemical recurrent prostate cancer. This is an ASCO Meeting Abstract from the 2020 Genitourinary Cancers Symposium. This abstract does not include a ...

Upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between patients whose MRI examinations were clinically interpreted using PI-RADS Version ...

PI-RADS version 2.1 demonstrated improved detection of clinically significant prostate cancer in the transition zone. For detecting clinically significant prostate cancer (csPCa), prostate imaging ...